Epidaza (chidamide) - Chipscreen
Alecensa (alectinib) - Roche
Zinapar (darinaparsin) - Solasia, Meiji Seika, Nippon Kayaku
Folotyn (pralatrexate) - Aurobindo
Istodax (romidepsin) - Astellas, BMS
Adcetris (brentuximab vedotin) - Takeda, Pfizer
Fodosine (forodesine) - Mundipharma, BioCryst
Ontak (denileukin diftitox) - Eisai, TSD Japan
https://meetings-api.hematology.org/api/abstract/vmpreview/296002
 
Hideki Uryu1; Tsuyoshi Muta2; Mitsumasa Watanabe3; Kosei Matsue4; Tatsuo Ichinohe5; Atsushi Takahata6; Masashi Sawa7; Nobuyuki Takayama8; Takafumi Yokota9; Hiromichi Takahashi10; Nobuhiko Yamauchi11; Taku Tsukamoto12; Kunihiro Tsukasaki13; Motoaki Shiratsuchi14; Kentaro Ido15; Yasushi Takamatsu16; Kisato Nosaka17; Tadakazu Kondo18; Tomoko Narita19; Junichiro Yuda20; Masaki Hayashi21; Ryosuke Naka22; Hiroaki Fujimori22; Yuichi Baba22; Mitsufumi Nishio22; Kenji Ishitsuka23; Koji Izutsu24
 
Nov 4, 2025
 
Next